LB 50016

Drug Profile

LB 50016

Latest Information Update: 22 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator LG Chem Investment
  • Class Antidepressants; Anxiolytics; Cyclic S oxides; Small molecules; Thiazoles
  • Mechanism of Action Serotonin 1A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders; Major depressive disorder

Most Recent Events

  • 13 May 2003 No development reported - Preclinical for Anxiety disorders in South Korea (unspecified route)
  • 13 May 2003 No development reported - Preclinical for Depression in South Korea (unspecified route)
  • 14 Jan 2000 Preclinical development for Anxiety disorders in South Korea (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top